Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Hair transplant worked for a patient with a specific scalp condition after breast cancer chemotherapy.

Frontal fibrosing alopecia is a type of hair loss that usually happens after menopause.

FFA patients have higher metal levels in hair, possibly linked to product use.

Frontal fibrosing alopecia is linked to thyroid disease, lupus, vitiligo, and heart disease.

Most cases were lichen planus pigmentosus, highlighting the need for accurate diagnosis for proper treatment.

Common baldness, also known as Androgenetic Alopecia, is caused by a combination of genetic factors and hormones called androgens.

Women with AGA have higher lipid levels, increasing heart disease risk.

More research is needed to understand and treat frontal fibrosing alopecia.

Baldness is common in Korean men (60.5%), and those with a family history are 3.1 times more likely to have hairline recession.

Frontal fibrosing alopecia in men is often misdiagnosed and needs better diagnostic criteria and treatments.

Delgocitinib cream may help treat frontal fibrosing alopecia.

Early hair loss may increase the risk of prostate cancer, especially in African American men and those with frontal baldness.

Treatments for hair loss vary, but cell-based options may be the future.

Apoptosis may contribute to hair loss in androgenetic alopecia.

Hair loss in males involves inflammation, collagen buildup, and follicle damage, with severity increasing with age and baldness duration.

Bald areas have lower cell growth, more DNA damage, and increased cell death.

Wnt/β-catenin and TGF-β pathways affect hair loss, and activating Wnt/β-catenin could be a potential treatment.

Female pattern hair loss has unclear causes, possibly involving genetics, hormones, and environment, and needs better treatments.

New treatment combining PRP and SVF increases hair density in 6-12 weeks for androgenetic alopecia patients.

Multiphoton microscopy can non-invasively tell apart scarring from non-scarring hair loss and could aid in treatment.

Men with baldness have higher levels of specific proteins, suggesting local hormone production may play a role in hair loss.

5-alpha-reductase inhibitors may help stabilize or slow down hair loss in some frontal fibrosing alopecia patients, but more research is needed to confirm their effectiveness and safety.

Occipital scalp affects female hair loss; terminal/vellus ratio helps diagnose androgenetic alopecia.

Female pattern hair loss treatments vary in effectiveness and may have side effects.

Dermoscopy effectively diagnoses and evaluates female hair loss treatment.

The FFA-QLI is a reliable tool for assessing quality of life in women with severe Frontal Fibrosing Alopecia.

Frontal fibrosing alopecia is a poorly understood condition with increasing cases and unclear treatment effectiveness.

PRP injections improve hair density in male hair loss.

New hair transplant method allows for hair regrowth in the donor area and less scarring.